Everest Medicines Ltd
HKEX:1952
Income Statement
Earnings Waterfall
Everest Medicines Ltd
Revenue
|
125.9m
CNY
|
Cost of Revenue
|
-34.4m
CNY
|
Gross Profit
|
91.5m
CNY
|
Operating Expenses
|
-970.9m
CNY
|
Operating Income
|
-879.3m
CNY
|
Other Expenses
|
34.9m
CNY
|
Net Income
|
-844.5m
CNY
|
Income Statement
Everest Medicines Ltd
Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+1 933%
|
13
+1 065%
|
21
+61%
|
126
+510%
|
|
Gross Profit | |||||||||
Cost of Revenue |
0
|
0
|
0
|
(0)
|
(0)
|
(5)
|
(8)
|
(34)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+2 194%
|
8
+1 046%
|
13
+60%
|
92
+602%
|
|
Operating Income | |||||||||
Operating Expenses |
(446)
|
(688)
|
(1 086)
|
(1 049)
|
(1 263)
|
(1 413)
|
(1 238)
|
(971)
|
|
Selling, General & Administrative |
(156)
|
(303)
|
(448)
|
(424)
|
(537)
|
(583)
|
(467)
|
(381)
|
|
Research & Development |
(305)
|
(365)
|
(608)
|
(599)
|
(693)
|
(790)
|
(719)
|
(492)
|
|
Depreciation & Amortization |
(14)
|
(20)
|
(33)
|
(31)
|
(36)
|
(40)
|
(50)
|
(64)
|
|
Other Operating Expenses |
30
|
1
|
3
|
5
|
4
|
0
|
(2)
|
(34)
|
|
Operating Income |
(446)
N/A
|
(688)
-54%
|
(1 086)
-58%
|
(1 049)
+3%
|
(1 262)
-20%
|
(1 405)
-11%
|
(1 225)
+13%
|
(879)
+28%
|
|
Pre-Tax Income | |||||||||
Interest Income Expense |
(382)
|
(23)
|
(4 945)
|
47
|
(27)
|
(144)
|
(29)
|
85
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
1 303
|
1 250
|
(53)
|
|
Total Other Income |
(10)
|
(4 948)
|
(10)
|
(6)
|
(5)
|
(2)
|
1
|
3
|
|
Pre-Tax Income |
(838)
N/A
|
(5 658)
-575%
|
(6 041)
-7%
|
(1 009)
+83%
|
(1 294)
-28%
|
(247)
+81%
|
(3)
+99%
|
(844)
-29 582%
|
|
Net Income | |||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
Income from Continuing Operations |
(838)
|
(5 658)
|
(6 041)
|
(1 009)
|
(1 294)
|
(247)
|
(3)
|
(844)
|
|
Net Income (Common) |
(838)
N/A
|
(5 658)
-575%
|
(6 041)
-7%
|
(1 009)
+83%
|
(1 294)
-28%
|
(247)
+81%
|
(3)
+99%
|
(844)
-29 499%
|
|
EPS (Diluted) |
-3.81
N/A
|
-66.29
-1 640%
|
-20.58
+69%
|
-3.44
+83%
|
-4.39
-28%
|
-0.83
+81%
|
0
N/A
|
-2.7
N/A
|